Used primarily in research settings to study the role of lysophosphatidic acid (LPA) signaling pathways, particularly through the LPA2 receptor. It helps in understanding cellular processes like proliferation, survival, and migration, which are relevant in cancer biology and inflammation. This antagonist is also explored for its potential therapeutic applications in diseases where LPA2 receptor activity is implicated, such as fibrosis, cancer, and autoimmune disorders. Its ability to block LPA2 receptor signaling makes it a valuable tool for developing targeted treatments in these areas.